Company Filing History:
Years Active: 2015
Title: Innovations by Kenneth Jung in Cancer Treatment
Introduction
Kenneth Jung is a notable inventor based in San Francisco, CA, who has made significant contributions to the field of cancer diagnosis and treatment. His work primarily focuses on colorectal cancers, particularly those associated with the FGFR2 gene.
Latest Patents
Kenneth Jung holds a patent for "Methods and compositions for the diagnosis and treatment of cancer." This patent outlines innovative methods and compositions aimed at diagnosing and treating colorectal cancers that exhibit amplification or overexpression of the FGFR2 gene.
Career Highlights
Kenneth Jung is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His work at Genentech has allowed him to contribute to groundbreaking research in cancer treatment.
Collaborations
Throughout his career, Kenneth has collaborated with esteemed colleagues, including John Chant and Anthony S Guerrero. These collaborations have further enhanced the impact of his research and innovations in the field.
Conclusion
Kenneth Jung's contributions to cancer treatment through his innovative patent and work at Genentech highlight the importance of research and collaboration in advancing medical science. His efforts continue to pave the way for improved diagnostic and therapeutic methods in oncology.